🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Steven Cohen’s IONS Holdings & Trades

First Buy
Q4 2015
Duration Held
29 Quarters
Largest Add
Q3 2026
+1.23 M Shares
Current Position
1.23 M Shares
$54.82 M Value

Steven Cohen's IONS Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.23 M shares of Ionis Pharmaceuticals, Inc. (IONS) worth $54.82 M, representing 0.06% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 29 quarters.

Based on 13F filings, Steven Cohen has maintained a strategic position in IONS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 1.23 M shares. Largest reduction occurred in Q3 2021, reducing 757,600 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Ionis Pharmaceuticals (IONS) Holding Value Over Time

Track share changes against reported price movement

Quarterly Ionis Pharmaceuticals (IONS) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +1.23 M New Buy 1.23 M $44.65
Q3 2025 -292,647 Sold Out 0 $0.00
Q2 2025 +5,443 Add 1.90% 292,647 $39.51
Q1 2025 +287,204 New Buy 287,204 $30.17
Q3 2024 -137,210 Sold Out 0 $0.00
Q2 2024 -149,392 Reduce 52.13% 137,210 $47.66
Q1 2024 -682,198 Reduce 70.42% 286,602 $43.35
Q4 2023 +827,300 Add 584.66% 968,800 $50.59
Q3 2023 -62,900 Reduce 30.77% 141,500 $45.36
Q2 2023 +108,515 Add 113.17% 204,400 $41.03
Q1 2023 +95,885 New Buy 95,885 $35.74
Q3 2022 -13,185 Sold Out 0 $0.00
Q2 2022 +13,185 New Buy 13,185 $37.01
Q1 2022 -53,981 Sold Out 0 $0.00
Q4 2021 -165,319 Reduce 75.38% 53,981 $30.44
Q3 2021 -757,600 Reduce 77.55% 219,300 $33.54
Q2 2021 +976,900 New Buy 976,900 $39.89
Q1 2021 -402,400 Sold Out 0 $0.00
Q4 2020 +113,908 Add 39.48% 402,400 $56.54
Q3 2020 +113,867 Add 65.21% 288,492 $47.45
Q2 2020 +169,052 Add 3033.41% 174,625 $58.96
Q1 2020 +5,573 New Buy 5,573 $47.19
Q4 2018 -86,031 Sold Out 0 $0.00
Q3 2018 +86,031 New Buy 86,031 $51.57
Q4 2017 -25,000 Sold Out 0 $0.00
Q3 2017 +25,000 New Buy 25,000 $50.72
Q2 2016 -80,600 Sold Out 0 $0.00
Q1 2016 -217,300 Reduce 72.94% 80,600 $40.50
Q4 2015 +297,900 New Buy 297,900 $61.93

Steven Cohen's Ionis Pharmaceuticals Investment FAQs

Steven Cohen first purchased Ionis Pharmaceuticals, Inc. (IONS) in Q4 2015, acquiring 297,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Ionis Pharmaceuticals, Inc. (IONS) for 29 quarters since Q4 2015.

Steven Cohen's largest addition to Ionis Pharmaceuticals, Inc. (IONS) was in Q3 2026, adding 1,227,788 shares worth $54.82 M.

According to the latest 13F filing for Q3 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,227,788 shares of Ionis Pharmaceuticals, Inc. (IONS), valued at approximately $54.82 M.

As of the Q3 2026 filing, Ionis Pharmaceuticals, Inc. (IONS) represents approximately 0.06% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Ionis Pharmaceuticals, Inc. (IONS) was 1,227,788 shares, as reported at the end of Q3 2026.